Log in

NASDAQ:CBLICleveland BioLabs SEC Filings & 10K Form

$2.24
0.00 (0.00 %)
(As of 07/3/2020 04:00 PM ET)
Add
Compare
Today's Range
$2.21
Now: $2.24
$2.42
50-Day Range
$1.52
MA: $2.02
$4.26
52-Week Range
$0.50
Now: $2.24
$5.00
Volume525,867 shs
Average Volume3.52 million shs
Market Capitalization$25.54 million
P/E RatioN/A
Dividend YieldN/A
Beta0.95

SEC Filings

Cleveland BioLabs (NASDAQ:CBLI) SEC Filings

DateFilerForm TypeView
06/11/2020
3:49 PM
ARMISTICE CAPITAL, LLC (Filed by)
Cleveland BioLabs (Subject)
Form SC 13G
06/04/2020
4:15 PM
Cleveland BioLabs (Filer)
Form D
Notice of Exempt Offering of Securities 
06/02/2020
7:49 AM
Cleveland BioLabs (Filer)
Form 424B5
05/31/2020
11:15 PM
Cleveland BioLabs (Filer)
Form EFFECT
05/29/2020
4:06 PM
Cleveland BioLabs (Filer)
Form 424B3
05/15/2020
8:00 AM
Cleveland BioLabs (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/15/2020
7:46 AM
Cleveland BioLabs (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/04/2020
7:01 AM
Cleveland BioLabs (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/14/2020
5:27 PM
Cleveland BioLabs (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
03/31/2020
4:28 PM
Cleveland BioLabs (Filer)
Form NT 10-K
01/24/2020
3:51 PM
Cleveland BioLabs (Subject)
HARPEL JAMES W (Filed by)
Form SC 13G
12/23/2019
4:00 PM
Cleveland BioLabs (Issuer)
Zosh Christopher (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
12/18/2019
4:00 PM
Cleveland BioLabs (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/03/2019
3:31 PM
Cleveland BioLabs (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/15/2019
3:30 PM
Cleveland BioLabs (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/14/2019
3:45 PM
Cleveland BioLabs (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
10/23/2019
5:07 AM
Cleveland BioLabs (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/23/2019
3:15 PM
Cleveland BioLabs (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/14/2019
7:45 AM
Cleveland BioLabs (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/14/2019
7:28 AM
Cleveland BioLabs (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/30/2019
3:45 PM
Cleveland BioLabs (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/15/2019
7:45 AM
Cleveland BioLabs (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/15/2019
7:30 AM
Cleveland BioLabs (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/29/2019
3:30 PM
Cleveland BioLabs (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/15/2019
7:29 AM
Cleveland BioLabs (Filer)
Form DEF 14A
03/15/2019
7:24 AM
Cleveland BioLabs (Filer)
Form DEFA14A
03/07/2019
7:15 AM
Cleveland BioLabs (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/07/2019
7:03 AM
Cleveland BioLabs (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
11/14/2018
7:29 AM
Cleveland BioLabs (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/14/2018
7:24 AM
Cleveland BioLabs (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/15/2018
10:03 AM
Cleveland BioLabs (Issuer)
Fedyunin Ivan (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
08/14/2018
4:15 PM
Cleveland BioLabs (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/14/2018
4:01 PM
Cleveland BioLabs (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/14/2018
3:45 PM
Cleveland BioLabs (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/10/2018
4:09 PM
Cleveland BioLabs (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/06/2018
4:01 PM
Cleveland BioLabs (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/19/2018
4:05 PM
Cleveland BioLabs (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
05/15/2018
7:16 AM
Cleveland BioLabs (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/15/2018
7:00 AM
Cleveland BioLabs (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/01/2018
7:12 AM
Cleveland BioLabs (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/28/2018
4:03 PM
Cleveland BioLabs (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/21/2018
3:33 PM
Cleveland BioLabs (Filer)
Form 424B3
03/12/2018
3:18 PM
Cleveland BioLabs (Filer)
Form DEFA14A
03/12/2018
3:16 PM
Cleveland BioLabs (Filer)
Form DEF 14A
03/06/2018
7:03 AM
Cleveland BioLabs (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/06/2018
6:35 AM
Cleveland BioLabs (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
02/28/2018
11:00 AM
ALPHA CAPITAL ANSTALT (Filed by)
Cleveland BioLabs (Subject)
Form SC 13G/A
01/04/2018
11:57 AM
Cleveland BioLabs (Subject)
SABBY MANAGEMENT, LLC (Filed by)
Form SC 13G/A
This page was last updated on 7/5/2020 by MarketBeat.com Staff

30 Days of MarketBeat All Access for $1.00

Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools:

  • Best-in-Class Portfolio Monitoring

    View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.

  • Stock Ideas and Recommendations

    Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.

  • Advanced Stock Screeners and Research Tools

    Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.